8-K filing — CNS Pharmaceuticals, Inc. (CNSP)
Filed: 2026-07-02 AccNo: 0001683168-26-005233 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
CNS Pharmaceuticals Q2 EPS $(0.38) Misses $(0.24) Estimate
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.24) by 58.33 percent. This is a 94.08 percent increase over losses of $(6.42) per share
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 12, 2026, 12:03 PM
- Checked
- Aug 12, 2026, 12:03 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading